Felicia Marie Knaul
费利西亚·纳尔
PhD
Professor; Director, Institute for Advanced Study of the Americas; Founding Director, Tómatelo a Pecho教授；美洲高等研究所所长；乳腺癌倡导项目创始主任
👥Biography 个人简介
Pioneer in global cancer control and palliative care access whose personal breast cancer experience in Mexico galvanized a landmark movement to extend opioid analgesics to millions denied pain relief. Her Lancet Commission on Global Access to Palliative Care catalyzed policy change across 20+ countries and reshaped WHO essential medicines guidance.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Lancet Commission on Palliative Care and Pain Relief
Co-chaired the 2017 Lancet Commission establishing the concept of serious health-related suffering (SHS), documenting a global palliative care crisis affecting 61 million people annually and generating actionable policy frameworks adopted by WHO and 20+ governments.
Breast Cancer Advocacy in Latin America
Founded Tómatelo a Pecho in Mexico, transforming public awareness and early detection rates for breast cancer across Latin America and demonstrating how patient-advocate-led movements can drive systemic change in LMIC health systems.
Representative Works 代表性著作
Alleviating the access abyss in palliative care and pain relief — an imperative of universal health coverage
The Lancet (2018)
Commission report quantifying the global opioid analgesic shortage and outlining an affordable policy package to relieve serious health-related suffering worldwide.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 费利西亚·纳尔 的研究动态
Follow Felicia Marie Knaul's research updates
留下邮箱，当我们发布与 Felicia Marie Knaul（University of Miami Miller School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment